Cardinal Health, Inc.
CAH
Peringkat dalam Saham
#399
Cardinal Health, Inc. operates as a global, integrated provider of healthcare... Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.
Harga Saham
$257.03
Terakhir disinkronkan: 2026-10-20
Kapitalisasi Pasar
$59.52B
Perubahan (1 hari)
1.57%
Perubahan (1 tahun)
61.98%
Negara
US
Perdagangan Cardinal Health, Inc. (CAH)
Kategori
Healthcare
Pendapatan untuk Cardinal Health, Inc. (CAH)
Pendapatan pada Jun 2026 TTM: $254.25B
Menurut laporan keuangan terbaru dari Cardinal Health, Inc., pendapatan saat ini (TTM) adalah $254.25B. Pada tahun 2024, perusahaan menghasilkan pendapatan sebesar $226.83B peningkatan dibandingkan pendapatan pada tahun 2023 yang sebesar $204.98B. Pendapatan adalah jumlah total yang dihasilkan dari penjualan barang atau jasa. Tidak seperti laba, tidak ada pengeluaran yang dikurangkan.
Riwayat pendapatan Cardinal Health, Inc. dari 2000 hingga 2026
Pendapatan pada akhir setiap tahun
| Tahun | Pendapatan | Mengubah |
|---|---|---|
| 2026 (TTM) | $254.25B | 14.23% |
| 2025 | $222.58B | -1.87% |
| 2024 | $226.83B | 10.66% |
| 2023 | $204.98B | 13.04% |
| 2022 | $181.33B | 11.61% |
| 2021 | $162.47B | 6.24% |
| 2020 | $152.92B | 5.08% |
| 2019 | $145.53B | 6.38% |
| 2018 | $136.81B | 5.26% |
| 2017 | $129.98B | 6.94% |
| 2016 | $121.55B | 18.55% |
| 2015 | $102.53B | 12.57% |
| 2014 | $91.08B | -9.90% |
| 2013 | $101.09B | -6.01% |
| 2012 | $107.55B | 4.78% |
| 2011 | $102.64B | 4.20% |
| 2010 | $98.50B | 2.62% |
| 2009 | $95.99B | 9.82% |
| 2008 | $87.41B | 0.64% |
| 2007 | $86.85B | 9.02% |
| 2006 | $79.66B | 9.63% |
| 2005 | $72.67B | 12.62% |
| 2004 | $64.52B | 13.73% |
| 2003 | $56.73B | 10.94% |
| 2002 | $51.14B | 6.65% |
| 2001 | $47.95B | 25.03% |
| 2000 | $38.35B | 0.00% |
Pendapatan untuk perusahaan serupa atau pesaing
| Perusahaan | Pendapatan | Perbedaan Pendapatan | Negara |
|---|---|---|---|
| $410.98B | 61.65% |
US
|
|
| - | - |
US
|
|
| - | - |
US
|
|
| $7.64B | -96.99% |
AU
|
|
| $13.60B | -94.65% |
US
|
